Upload Avatar (500 x 500)
Ningqiang Gong
gongn@ustc.edu.cn
English, Chinese
Anhui
University of Science and Technology of China
Basic Medical Sciences
  • 2014.9-2019.7 PhD: Tsinghua University, Department of Chemistry
  • 2010.9-2014.7 Bachelor's: Capital Medical University
  • 2023 National Youth Talent Project
  • 2022 Burroughs Young Investigator Award, Biomedical Engineering Society of America
  • 2021 First Prize in Natural Science, Beijing Municipal Government
  • 2020 Excellent Doctoral Dissertation Award, Chinese Chemical Society/Jingbo Technology Co., Ltd.
  • 2019 Special Award of the President, Chinese Academy of Sciences
  • 2024.4-present - University of Science and Technology of China, School of Life Sciences and Medicine - Specially Appointed Professor
  • 2023.12-2024.4 - University of Science and Technology of China, National Research Center for Microscale Material Science - Specially Appointed Professor
  • 2019.9-2023.11 - University of Pennsylvania, Department of Bioengineering - Postdoctoral Researcher
  • 2023: National Youth Talent Project
  • 2022: Burroughs Young Investigator Award, Biomedical Engineering Society of America
  • 2021: First Prize in Natural Science, Beijing Municipal Government
  • 2020: Excellent Doctoral Dissertation Award, Chinese Chemical Society/Jingbo Technology Co., Ltd.
  • 2019: Special Award of the President, Chinese Academy of Sciences
Biomaterials
Drug Delivery
Gene, Protein, and Cell Engineering
  • Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery, N. Gong, W. Zhong, M.-G.Alameh, X. Han, L. Xue, R. El-Mayta, G. Zhao, A. E. Vaughan, Z. Qin, F. Xu, A. G. Hamilton, D. Kim, J. Xu, J. Kim, X. Teng, J. Li, X.-J. Liang, D. Weissman, W. Guo, M. J. Mitchell, 2024
  • Enhancing in situ cancer vaccines using delivery technologies, N. Gong, M.-G.Alameh, R. El-Mayta, L. Xue, D. Weissman, M. J. Mitchell, 2024
  • Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager, N. Gong, X. Han, L. Xue, M. M Billingsley, X. Huang, R. El-Mayta, J. Qin, N. C Sheppard, C. H June, M. J Mitchell, 2024
  • In situ PEGylation of CAR T cells alleviates cytokine release syndrome and neurotoxicity, N. Gong, X. Han, L. Xue, R. El-Mayta, A. E. Metzloff, M. M. Billingsley, A. G. Hamilton, M. J. Mitchell, 2023
  • Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel, X. Li, N. Gong, F. Tian, S. Zhang, Y. Zhang, Y. Wang, G. Qing, Y. Wang, F. Li, Y. Xu, L. Zhang, J. Wang, Q. Ni, Y. Gan, C. Gu, H. Jiang, X. Huang, X. Shi, T. Zhang, Y. Wu, X.-J. Liang, 2023
  • Nanomaterials for T-cell cancer immunotherapy, N. Gong, N. C. Sheppard, M. M. Billingsley, C. H. June, M. J. Mitchell, 2021
  • Proton-driven transformable nanovaccine for cancer immunotherapy, N. Gong, Y. Zhang, X. Teng, Y. Wang, S. Huo, G. Qing, Q. Ni, X. Li, J. Wang, X. Ye, T. Zhang, S. Chen, Y. Wang, J. Yu, P. C. Wang, Y. Gan, J. Zhang, M. J. Mitchell, J. Li, X.-J. Liang, 2020
  • Carbon dot-supported atomically-dispersed gold as a mitochondrial oxidative stress amplifier for cancer treatment, N. Gong, X. Ma, X. Ye, Q. Zhou, X. Chen, X. Tan, S. Yao, S. Huo, T. Zhang, S. Chen, X. Teng, X. Hu, J. Yu, Y. Gan, H. Jiang, J. Li, X.-J. Liang, 2019
Biomaterials Drug Delivery Gene Engineering Protein Engineering Cell Engineering Clinical Problems Cancer Immunotherapy Nanoparticles Nucleic Acid Delivery Immune Cell Modification

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.